Mon 8 Sep 2008

AMRI to receive $1.5M from Bristol-Myers

Posted by heaven under Uncategorized
Comments Off 
Albany Molecular Research Inc. is in line to receive another $1.5 million milestone payment from Bristol-Myers Squibb Co. (BMY)

 

Mon 8 Sep 2008

Proteolix gets $79M in 3rd round

Posted by heaven under Uncategorized
Comments Off 
Proteolix Inc., which focuses on the discovery and development of therapeutics that target protein degradation pathways in cancer and autoimmune diseases, said Monday it closed a third round of funding with $79 million.

 

Mon 8 Sep 2008

GlycoMimetics’ sickle cell drug enters human tests

Posted by heaven under Uncategorized
Comments Off 
GlycoMimetics Inc., which has developed an experimental drug to short-circuit painful sickle cell anemia flare-ups, started testing it in humans Aug. 28.

 

Mon 8 Sep 2008

Analysts upbeat about Affymax after it narrows its drug focus

Posted by heaven under Uncategorized
Comments Off 
Two years after a sparkling initial public offering, Affymax Inc. is pouring all its resources and cash into upsetting Amgen Inc.’s monopoly in the dialysis market.

 

Mon 8 Sep 2008

Top 50 Regional Companies #4

Posted by heaven under Uncategorized
Comments Off 
Employing about 5,600 people in Minnesota, Boston Scientific has two Twin Cities groups, in Arden Hills and Maple Grove, that focus on developing technologies used to diagnose and treat coronary artery disease, cardiac arrhythmias and heart failure.

 

— Next Page »

Oracle Tools, Pl/sql Tools - Sudan Calling Cards - Fantasyketten - Traditional Thanksgiving Recipes